The first GLP-1 drug, exenatide (the brand name is Byetta), was approved in 2005
For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory. Commenting on the topline results, Professor Graham Finlayson, chair in psychobiology at the University of Leeds, said it was striking to see retatrutide reaching the weight loss range historically associated with bariatric surgery and that the headline efficacy results are impressive, particularly the proportion of participants reported to achieve very large weight losses. He added: In principle, that broader pharmacology could produce larger effects on body weight and metabolism, although the full peer-reviewed data will be needed to understand the balance between efficacy, tolerability and discontinuation. While this clinical trial did not examine weight regain after stopping retatrutide, other studies have found that discontinuing weight-loss medications such as semaglutide and liraglutide typically results in near-total weight regain within about 18 months
Consider ergonomic keyboards, vertical mice, or trackball alternatives that reduce wrist strain
Book a Peptide Consultation in Dubai Start your personalized IGF-1 LR3 protocol at IV Wellness Lounge
It is both an amino acid and a neurotransmitter, as it helps in the production of the feel-good hormone serotonin
Pain Modulation: DSIP is hypothesized to have analgesic-like properties, possibly by influencing opioid receptor activity and modulating pain signal transmission pathways
-min.png)
